Olympics may have a negative impact on China's research
SIR -Your Editorial 'China's challenges' (Nature 454, 367-368; 2008) In Italy, the pharmaceutical industry is obliged to maintain the lowest prices in Europe. The new government has left these regulations unaltered in its economic programme for the next three years.
At the time of the unfortunate events of the Duilio Poggiolini era 15 years ago, Italy's per capita spending on pharmaceuticals was slightly below the European average. This spending has today fallen to €194 (US$290), against a European average of €270 -even though Italy has easier access to therapies than many other European countries and has more elderly citizens than any of them.
In the past seven years, governments of various political colours have made 18 separate cutbacks on pharmaceutical spending. The 30% difference from the European average indicates that our industry has not enjoyed government favours.
The pharmaceutical industry has nevertheless fought back against this difficult situation. Its exports have risen from 10% of total production to 53%, and today it boasts a surplus in its trade balance for medicines.
The replacement of the manager of the Italian medicines agency AIFA, as mentioned in your Editorial, occurred after a judicial enquiry. This was ratified by an independent judicial decision.
The pharmaceutical industry in Italy is represented by an association that belongs to the Italian employers' federation Confindustria. This association has implemented rigorous ethical rules to govern its members' conduct and, in representing the interests of the industry vis-à-vis the public institutions, totally respects their autonomy. Its sole request is that public institutions provide a regulatory framework that is fixed over time and can guarantee timescales and procedures in their authorization processes, in the same way as those in force in other European countries.
Sergio Dompé Farmindustria, Largo del Nazareno 3, 00187 Roma, Italy e-mail: morelli@farmindustria.it Atheism could be science's contribution to religion SIR -We were perplexed by your Editorial on the work of the Templeton Foundation ('Templeton's legacy' Nature 454, 253-254; 2008) . Surely science is about finding material explanations of the worldexplanations that can inspire those spooky feelings of awe, wonder and reverence in the hyper-evolved human brain.
Religion, on the other hand, is about humans thinking that awe, wonder and reverence are the clue to understanding a God-built Universe. (The same is true of religion's poor cousin, 'spirituality', which you slip into your Editorial rather as a creationist uses 'intelligent design'.) There is a fundamental conflict here, one that can never be reconciled until all religions cease making claims about the nature of reality.
The scientific study of religion is indeed full of big questions that need to be addressed, such as why belief in religion is negatively correlated with an acceptance of evolution. One could consider psychological studies of why humans are superstitious and believe impossible things, and comparative sociological studies of religion using materialist explanations of the rise and fall of the world's belief systems.
Perhaps the Templeton Foundation is thinking of funding such research. The outcome of such work, we predict, will not bring science and religion (or 'spirituality') any closer to one another. You suggest that science may bring about "advances in theological thinking". In reality, the only contribution that science can make to the ideas of religion is atheism.
